Orchard Therapeutics
Stock Forecast, Prediction & Price Target
Orchard Therapeutics Financial Estimates
Orchard Therapeutics Revenue Estimates
Orchard Therapeutics EBITDA Estimates
Orchard Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $2.59M N/A | $483K -81.38% | $6.98M 1346.37% | Avg: $97.86M Low: $60.91M High: $124.04M avg. 1300.89% | |||
Net Income
% change YoY
| $-151.97M N/A | $-36.34M 76.08% | $-7.88M 78.31% | Avg: $-82.18M Low: $-4.48M High: $-3.97M avg. -942.60% | |||
EBITDA
% change YoY
| $-148.37M N/A | $-35.54M 76.04% | $-8.07M 77.26% | Avg: $-97.86M Low: $-60.91M High: $-124.04M avg. -1111.37% | |||
EPS
% change YoY
| -$15.28 N/A | -$2.93 80.82% | -$0.61 79.18% | Avg: -$0.33 Low: -$0.35 High: -$0.31 avg. 45.90% | |||
Operating Expenses
% change YoY
| $158.71M N/A | $36.89M -76.75% | $36.14M -2.04% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Orchard Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -942.60% in 2025-2025.
We have gathered data from 2 analysts. Their low estimate is -4.48M, average is -82.18M and high is -3.97M.
What is Orchard Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1300.89% in 2025-2025.
We have gathered data from 3 analysts. Their low revenue estimate is $60.91M, average is $97.86M and high is $124.04M.
What is Orchard Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 45.90% in 2025-2025.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.35, average is -$0.33 and high is $-0.31.